| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000035724 |
| Receipt No. | R000040677 |
| Scientific Title | Prospective study of endoscopic ultrasound-guided hepaticogastrostomy combined with antegrade stenting using novel metal stent |
| Date of disclosure of the study information | 2019/01/31 |
| Last modified on | 2019/08/02 (Ver. 3) |
| Basic information | ||
| Public title | Prospective study of endoscopic ultrasound-guided hepaticogastrostomy combined with antegrade stenting using novel metal stent | |
| Acronym | Prospective study of endoscopic ultrasound-guided hepaticogastrostomy with antegrade stenting using novel stent | |
| Scientific Title | Prospective study of endoscopic ultrasound-guided hepaticogastrostomy combined with antegrade stenting using novel metal stent | |
| Scientific Title:Acronym | Prospective study of endoscopic ultrasound-guided hepaticogastrostomy with antegrade stenting using novel stent | |
| Region |
|
|
| Condition | ||
| Condition | Obstructive Jaundice | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the EUS-HGAS procedure success rate for unresectable malignant biliary obstructive cases using novel metal stent |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | EUS-HGAS procedure success rate |
| Key secondary outcomes | Type, frequency of adverse events.
3 months after EUS - HGAS stent patency. Clinical efficacy rate. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | EUS-HGS with EUS-AS using novet metal stent(Zilver type 2) | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | nonresectable advanced malignant tumor case
Cases requiring biliary duct drainage due to malignant bile duct obstruction Difficult cases of biliary drainage via Vater papilla approach Cases in which survival is expected for more than 3 months |
|||
| Key exclusion criteria | Difficult cases of endoscopic approach
Perfomance status 4 case Cases with serious complications in other organs Informed consent case not available |
|||
| Target sample size | 25 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Osaka Medical College Hospital | ||||||
| Division name | Gastrointestinal Division | ||||||
| Zip code | 569-8686 | ||||||
| Address | 2-7 Daigakumachi, Takatsuki, Osaka | ||||||
| TEL | +81726831221 | ||||||
| higuchi@osaka-med.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Osaka Medical College Hospital | ||||||
| Division name | Gastrointestinal Division | ||||||
| Zip code | 569-8686 | ||||||
| Address | 2-7 Daigakumachi, Takatsuki, Osaka | ||||||
| TEL | +81726831221 | ||||||
| Homepage URL | |||||||
| onchannopasocon@yahoo.co.jp | |||||||
| Sponsor | |
| Institute | Osaka Medical College |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Osaka Medical College |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Osaka Medical College |
| Address | 2-7 Daigakumachi, Takatsuki, Osaka |
| Tel | 0726-83-1221 |
| rinri@osaka-med.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 大阪医科大学付属病院(大阪府) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB | |||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040677 |